2022 Q3 Form 10-Q Financial Statement
#000165495422010468 Filed on August 02, 2022
Income Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
Revenue | $0.00 | $19.00K | $0.00 |
YoY Change | -100.0% | 171.43% | |
Cost Of Revenue | $1.655M | $1.662M | $1.722M |
YoY Change | -2.82% | -9.43% | 2.93% |
Gross Profit | -$1.655M | -$1.643M | -$1.722M |
YoY Change | -2.3% | -10.12% | 2.93% |
Gross Profit Margin | -8647.37% | ||
Selling, General & Admin | $1.186M | $1.561M | $2.026M |
YoY Change | -13.3% | -4.12% | 85.87% |
% of Gross Profit | |||
Research & Development | $1.610M | $1.786M | $1.160M |
YoY Change | 129.34% | 74.07% | 93.33% |
% of Gross Profit | |||
Depreciation & Amortization | $765.0K | $765.0K | $456.0K |
YoY Change | -19.64% | -19.39% | 2.24% |
% of Gross Profit | |||
Operating Expenses | $2.910M | $3.460M | $3.298M |
YoY Change | 32.94% | 24.59% | 82.01% |
Operating Profit | -$4.565M | -$5.103M | -$5.020M |
YoY Change | 17.56% | 10.81% | 44.05% |
Interest Expense | $114.0K | $163.0K | $174.0K |
YoY Change | -37.36% | -12.83% | -7.94% |
% of Operating Profit | |||
Other Income/Expense, Net | -$7.000K | $4.000K | $1.250M |
YoY Change | -450.0% | 300.0% | |
Pretax Income | -$4.962M | -$353.0K | -$6.928M |
YoY Change | -45.52% | -94.87% | -6.0% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$4.962M | -$353.0K | -$6.928M |
YoY Change | -45.52% | -94.87% | -6.02% |
Net Earnings / Revenue | -1857.89% | ||
Basic Earnings Per Share | -$0.03 | $0.00 | -$0.03 |
Diluted Earnings Per Share | -$0.03 | $0.00 | -$0.03 |
COMMON SHARES | |||
Basic Shares Outstanding | 222.8M shares | 219.1M shares | 217.3M shares |
Diluted Shares Outstanding | 221.8B shares | 219.1M shares | 217.3M shares |
Balance Sheet
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $39.92M | $43.27M | $46.32M |
YoY Change | 19.47% | 101.33% | 163.15% |
Cash & Equivalents | $39.92M | $43.27M | $46.32M |
Short-Term Investments | |||
Other Short-Term Assets | $1.375M | $2.673M | $2.588M |
YoY Change | -49.65% | -23.03% | 331.33% |
Inventory | $9.903M | $7.923M | |
Prepaid Expenses | $1.375M | $1.137M | |
Receivables | $4.000K | $15.00K | $6.000K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $51.20M | $53.88M | $48.91M |
YoY Change | 41.6% | 115.78% | 168.63% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $20.10M | $20.43M | $20.86M |
YoY Change | -2.38% | -2.75% | -2.66% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $8.065M | $8.026M | $15.94M |
YoY Change | -48.9% | -49.14% | 1.55% |
Total Long-Term Assets | $64.13M | $62.90M | $71.56M |
YoY Change | -10.39% | -13.29% | -5.63% |
TOTAL ASSETS | |||
Total Short-Term Assets | $51.20M | $53.88M | $48.91M |
Total Long-Term Assets | $64.13M | $62.90M | $71.56M |
Total Assets | $115.3M | $116.8M | $120.5M |
YoY Change | 7.06% | 19.76% | 28.11% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.275M | $1.429M | $1.367M |
YoY Change | 553.85% | 119.17% | 263.56% |
Accrued Expenses | $2.040M | $2.062M | $2.298M |
YoY Change | -0.92% | -2.0% | 9.43% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $5.333M | $3.971M | $2.628M |
YoY Change | 226.87% | ||
Total Short-Term Liabilities | $8.605M | $8.568M | $9.327M |
YoY Change | 33.85% | 48.31% | 77.49% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $7.108M | $8.470M | $9.813M |
YoY Change | -42.26% | 9913.27% | |
Other Long-Term Liabilities | $33.12M | $33.15M | $36.23M |
YoY Change | -10.73% | -12.4% | 0.07% |
Total Long-Term Liabilities | $40.18M | $41.56M | $45.97M |
YoY Change | -18.67% | -17.11% | -5.49% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $8.605M | $8.568M | $9.327M |
Total Long-Term Liabilities | $40.18M | $41.56M | $45.97M |
Total Liabilities | $48.79M | $50.13M | $55.30M |
YoY Change | -12.63% | -10.35% | 2.6% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$215.4M | -$210.4M | -$210.0M |
YoY Change | 5.81% | 8.21% | 11.99% |
Common Stock | $256.8M | ||
YoY Change | 1110.28% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $66.54M | $66.65M | $65.17M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $115.3M | $116.8M | $120.5M |
YoY Change | 7.06% | 19.76% | 28.11% |
Cashflow Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$4.962M | -$353.0K | -$6.928M |
YoY Change | -45.52% | -94.87% | -6.02% |
Depreciation, Depletion And Amortization | $765.0K | $765.0K | $456.0K |
YoY Change | -19.64% | -19.39% | 2.24% |
Cash From Operating Activities | -$5.940M | -$4.174M | -$2.222M |
YoY Change | 77.74% | 12.48% | 7.03% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$128.0K | -$25.00K | -$60.00K |
YoY Change | 433.33% | -35.9% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$128.0K | -$25.00K | -$60.00K |
YoY Change | 433.33% | -35.9% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 2.858M | 1.211M | $2.440M |
YoY Change | -81.35% | -84.13% | -84.12% |
NET CHANGE | |||
Cash From Operating Activities | -5.940M | -4.174M | -$2.222M |
Cash From Investing Activities | -128.0K | -25.00K | -$60.00K |
Cash From Financing Activities | 2.858M | 1.211M | $2.440M |
Net Change In Cash | -3.210M | -2.988M | $180.0K |
YoY Change | -126.85% | -176.99% | -98.65% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$5.940M | -$4.174M | -$2.222M |
Capital Expenditures | -$128.0K | -$25.00K | -$60.00K |
Free Cash Flow | -$5.812M | -$4.149M | -$2.162M |
YoY Change | 75.17% | 12.99% | 4.14% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q4 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
1536000 | usd |
CY2021Q4 | urg |
Cash Pledged For Reclamation
CashPledgedForReclamation
|
7966000 | usd |
CY2022Q2 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
8026000 | usd |
CY2021Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
7966000 | usd |
CY2021Q4 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
35067000 | usd |
us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
-624000 | usd | |
CY2022Q2 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
34443000 | usd |
us-gaap |
Accretion Expense
AccretionExpense
|
246000 | usd | |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
6758000 | usd | |
us-gaap |
Development Costs
DevelopmentCosts
|
465000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3585000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2722000 | usd | |
us-gaap |
Accretion Expense
AccretionExpense
|
225000 | usd | |
us-gaap |
Exploration Expense
ExplorationExpense
|
1156000 | usd | |
us-gaap |
Development Costs
DevelopmentCosts
|
1949000 | usd | |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
4589000 | usd | |
CY2022Q2 | urg |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price66
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice66
|
0.69 | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-06-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-33905 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
UR-ENERGY INC | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
Z4 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
10758 West Centennial Road | ||
urg |
Proceeds From Options Exercised
ProceedsFromOptionsExercised
|
200000 | usd | |
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 200 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Littleton | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
urg |
Proceeds From Options Exercised
ProceedsFromOptionsExercised
|
1200000 | usd | |
CY2022Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
300000 | usd |
urg |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod
|
0 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
0 | shares | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
216782694 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
219246028 | shares |
urg |
Disposal Billings
DisposalBillings
|
7000 | usd | |
CY2022Q2 | urg |
Disposal Billings
DisposalBillings
|
19000 | usd |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001375205 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
urg |
Number Of Rsus Unvested Granted
NumberOfRsusUnvestedGranted
|
0 | shares | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
500000 | usd | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.72 | ||
CY2022Q2 | urg |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number75
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber75
|
9918999 | shares |
CY2021Q4 | us-gaap |
Partners Capital
PartnersCapital
|
248319000 | usd |
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CO | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
80127 | ||
dei |
City Area Code
CityAreaCode
|
720 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
981-4588 | ||
dei |
Security12b Title
Security12bTitle
|
Common stock | ||
dei |
Trading Symbol
TradingSymbol
|
URG | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NYSEAMER | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
222806028 | shares |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
7923000 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
0 | usd |
CY2022Q2 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
34443000 | usd |
CY2021Q4 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
35067000 | usd |
CY2022Q2 | us-gaap |
Capital Leased Assets Gross
CapitalLeasedAssetsGross
|
20427000 | usd |
CY2021Q4 | us-gaap |
Capital Leased Assets Gross
CapitalLeasedAssetsGross
|
21260000 | usd |
CY2022Q2 | us-gaap |
Assets
Assets
|
116774000 | usd |
CY2022Q2 | us-gaap |
Notes Payable
NotesPayable
|
8416000 | usd |
CY2021Q4 | us-gaap |
Notes Payable
NotesPayable
|
11060000 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
40384000 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
|
19957000 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
20427000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
40367000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
|
19107000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
21260000 | usd |
CY2022Q2 | us-gaap |
Partners Capital
PartnersCapital
|
252182000 | usd |
us-gaap |
Revenues
Revenues
|
19000 | usd | |
CY2021Q2 | us-gaap |
Revenues
Revenues
|
7000 | usd |
CY2022Q2 | us-gaap |
Revenues
Revenues
|
19000 | usd |
us-gaap |
Revenues
Revenues
|
7000 | usd | |
CY2022Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1662000 | usd |
CY2021Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1835000 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
3384000 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
3508000 | usd | |
CY2022Q2 | us-gaap |
Gross Profit
GrossProfit
|
-1643000 | usd |
CY2021Q2 | us-gaap |
Gross Profit
GrossProfit
|
-1828000 | usd |
us-gaap |
Gross Profit
GrossProfit
|
-3365000 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
-3501000 | usd | |
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
3460000 | usd |
CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2777000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
6758000 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
4589000 | usd | |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5103000 | usd |
CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4605000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10123000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8090000 | usd | |
CY2022Q2 | us-gaap |
Interest Expense
InterestExpense
|
163000 | usd |
CY2021Q2 | us-gaap |
Interest Expense
InterestExpense
|
187000 | usd |
us-gaap |
Interest Expense
InterestExpense
|
337000 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
376000 | usd | |
CY2022Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-4888000 | usd |
CY2021Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
2920000 | usd |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1915000 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
6324000 | usd | |
CY2022Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
21000 | usd |
CY2021Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-71000 | usd |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
10000 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-367000 | usd | |
CY2022Q2 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
4000 | usd |
CY2021Q2 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
904000 | usd |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
1254000 | usd | |
us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
906000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7281000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14251000 | usd | |
us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
-7231000 | usd | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-353000 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6879000 | usd |
CY2022Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
|
158000 | usd |
CY2021Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
|
34000 | usd |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
|
50000 | usd | |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
|
253000 | usd | |
CY2022Q2 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
-195000 | usd |
CY2021Q2 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
-6845000 | usd |
us-gaap |
Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
|
-13998000 | usd | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
CY2021Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.08 | ||
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0 | |
CY2021Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.08 | ||
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
219146082 | shares |
CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
190240544 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
218205337 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
186089756 | shares | |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
219146082 | shares |
CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
190240544 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
218205337 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
186089756 | shares | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
34096000 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1078000 | usd |
CY2021Q1 | urg |
Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
|
551000 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
15237000 | usd |
CY2021Q1 | urg |
Less Amount Assigned To Warrant Liability Amount
LessAmountAssignedToWarrantLiabilityAmount
|
-2604000 | usd |
CY2021Q1 | urg |
Less Share Issue Costs
LessShareIssueCosts
|
-1307000 | usd |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
231000 | usd |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7153000 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
40129000 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
94000 | usd |
CY2021Q2 | urg |
Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
|
1245000 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
6930000 | usd |
CY2021Q2 | urg |
Less Share Issue Costs
LessShareIssueCosts
|
-218000 | usd |
CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
259000 | usd |
CY2021Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-6845000 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
41594000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
69386000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
171000 | usd |
CY2022Q1 | urg |
Exercise Of Warrants Amount
ExerciseOfWarrantsAmount
|
308000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2128000 | usd |
CY2022Q1 | urg |
Less Share Issue Costs
LessShareIssueCosts
|
-53000 | usd |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
261000 | usd |
CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7036000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
65165000 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
56000 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1185000 | usd |
CY2022Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1429000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
854000 | usd |
CY2022Q2 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
1816000 | usd |
CY2021Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
1927000 | usd |
CY2022Q2 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
175000 | usd |
CY2021Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
83000 | usd |
CY2022Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
3420000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2864000 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3971000 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1305000 | usd |
CY2021Q4 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
43000 | usd |
CY2022Q2 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
43000 | usd |
CY2022Q2 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
3928000 | usd |
CY2021Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
1262000 | usd |
CY2022Q2 | urg |
Less Share Issue Costs
LessShareIssueCosts
|
-30000 | usd |
CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
464000 | usd |
CY2022Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-195000 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
66645000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7281000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14251000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
725000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
490000 | usd | |
us-gaap |
Assets Fair Value Adjustment
AssetsFairValueAdjustment
|
3384000 | usd | |
us-gaap |
Assets Fair Value Adjustment
AssetsFairValueAdjustment
|
3508000 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
624000 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1017000 | usd | |
us-gaap |
Depreciation
Depreciation
|
909000 | usd | |
us-gaap |
Depreciation
Depreciation
|
892000 | usd | |
us-gaap |
Accretion Expense
AccretionExpense
|
225000 | usd | |
us-gaap |
Accretion Expense
AccretionExpense
|
246000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
22000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
24000 | usd | |
urg |
Gain On Loan Forgiveness
GainOnLoanForgiveness
|
0 | usd | |
urg |
Gain On Loan Forgiveness
GainOnLoanForgiveness
|
-903000 | usd | |
us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
1915000 | usd | |
us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
-6324000 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
7000 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-369000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
11000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3384000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3616000 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
243000 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
246000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
556000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
360000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6396000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5791000 | usd | |
us-gaap |
Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
|
85000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-39000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-85000 | usd | |
us-gaap |
Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
|
39000 | usd | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
3313000 | usd | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
22167000 | usd | |
urg |
Share Issue Costs
ShareIssueCosts
|
-83000 | usd | |
urg |
Share Issue Costs
ShareIssueCosts
|
-1525000 | usd | |
urg |
Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
|
421000 | usd | |
urg |
Proceeds From Exercise Of Warrants And Stock Options
ProceedsFromExerciseOfWarrantsAndStockOptions
|
2359000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3651000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
23001000 | usd | |
urg |
Effects Of Foreign Exchange Rate Changes On Cash
EffectsOfForeignExchangeRateChangesOnCash
|
-32000 | usd | |
urg |
Effects Of Foreign Exchange Rate Changes On Cash
EffectsOfForeignExchangeRateChangesOnCash
|
53000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2862000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
17224000 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
54155000 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12127000 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
51293000 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
29351000 | usd |
CY2021Q4 | us-gaap |
Asset Retirement Obligation
AssetRetirementObligation
|
29915000 | usd |
us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1. Nature of Operations</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Ur-Energy Inc. (the “Company”) was incorporated on March 22, 2004, under the laws of the Province of Ontario. The Company continued under the Canada Business Corporations Act on August 8, 2006. The Company is an exploration stage issuer, as defined by United States Securities and Exchange Commission (“SEC”). The Company is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located primarily in Wyoming. The Company commenced uranium production at its Lost Creek Project in Wyoming in 2013.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Due to the nature of the uranium recovery methods used by the Company on the Lost Creek Property, and the definition of “mineral reserves” under Subpart 1300 to Regulation S-K (“S-K 1300”), the Company has not determined whether the properties contain mineral reserves. This was true while the Company reported its mineral resources pursuant to Canadian National Instrument 43-101 (“NI 43-101”). The Company’s report <em>The Lost Creek ISR Uranium Property, Sweetwater County, Wyoming,</em> March 7, 2022 (the “Lost Creek Report”) outlines the potential viability of the Lost Creek Property. The recoverability of amounts recorded for mineral properties is dependent upon the discovery of economic resources, the ability of the Company to obtain the necessary financing to develop the properties and upon attaining future profitable production from the properties or sufficient proceeds from disposition of the properties.</p> | ||
CY2022Q2 | us-gaap |
Cash
Cash
|
6287000 | usd |
CY2021Q4 | us-gaap |
Cash
Cash
|
9068000 | usd |
CY2022Q2 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
36980000 | usd |
CY2021Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
37121000 | usd |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
43267000 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
46189000 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
8470000 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
11136000 | usd |
CY2022Q2 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
54000 | usd |
CY2021Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
76000 | usd |
CY2022Q2 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
8416000 | usd |
CY2021Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
11060000 | usd |
us-gaap |
Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
|
225000 | usd | |
CY2022Q2 | us-gaap |
Asset Retirement Obligation
AssetRetirementObligation
|
30140000 | usd |
us-gaap |
Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
|
3384000 | usd | |
us-gaap |
Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
|
3508000 | usd | |
CY2022Q2 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
1536000 | usd |
CY2022Q2 | urg |
Cash Pledged For Reclamation
CashPledgedForReclamation
|
8026000 | usd |
urg |
Beginning Balance Warrant Liabilities
BeginningBalanceWarrantLiabilities
|
6263000 | usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
114000 | usd | |
urg |
Mark To Market Revaluation Loss Gain
MarkToMarketRevaluationLossGain
|
-1915000 | usd | |
us-gaap |
Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
|
89000 | usd | |
urg |
Ending Balance Warrant Liabilities
EndingBalanceWarrantLiabilities
|
4145000 | usd | |
CY2022Q2 | urg |
Current Portion Of Warrant Liability
CurrentPortionOfWarrantLiability
|
1149000 | usd |
CY2022Q2 | urg |
Warrant Liability
WarrantLiability
|
2996000 | usd |
CY2022Q2 | urg |
Total
Total
|
4145000 | usd |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
219246028 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
216782694 | shares |
CY2021Q1 | urg |
Shares Issued Upon Public Offering
SharesIssuedUponPublicOffering
|
14722200 | shares |
CY2021Q1 | urg |
Warrants Issued To Purchase Common Shares
WarrantsIssuedToPurchaseCommonShares
|
7361100 | shares |
CY2021Q1 | us-gaap |
Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
|
0.90 | |
CY2021Q1 | urg |
Common Stock No Par Values
CommonStockNoParValues
|
1.35 | |
CY2021Q1 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
2208330 | shares |
CY2021Q1 | us-gaap |
Investment Sold Not Yet Purchased Balance Shares
InvestmentSoldNotYetPurchasedBalanceShares
|
1104165 | shares |
urg |
Warrants Issued To Purchase Common Shares
WarrantsIssuedToPurchaseCommonShares
|
16930530 | shares | |
CY2021Q1 | urg |
Common Shares Purchase
CommonSharesPurchase
|
8465265 | shares |
CY2021Q1 | urg |
Proceed From Warrant Exercises
ProceedFromWarrantExercises
|
15200000 | usd |
CY2021Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
1300000 | usd |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
13900000 | usd |
CY2021Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
200000 | usd |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
300000 | usd | |
urg |
Unamortized Stock Based Comoensation Expenses
UnamortizedStockBasedComoensationExpenses
|
900000 | usd | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
10064024 | shares |
CY2021Q4 | urg |
Outstanding Beginning Balance Weighted Average Exercise Price
OutstandingBeginningBalanceWeightedAverageExercisePrice
|
0.68 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
175000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.74 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
320025 | shares | |
urg |
Option Weighted Average Vesting Period
OptionWeightedAverageVestingPeriod
|
P1Y10M24D | ||
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.69 | |
CY2022Q2 | urg |
Number Of Options Outstanding
NumberOfOptionsOutstanding
|
9918999 | shares |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P2Y6M | ||
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
3870593 | usd |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
6322402 | shares |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P1Y10M24D | ||
urg |
Aggregate Intrinsic Value Exercisable
AggregateIntrinsicValueExercisable
|
2653072 | usd | |
CY2022Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
1.06 | |
CY2022Q2 | urg |
Number Of Options Outstandings
NumberOfOptionsOutstandings
|
8421835 | shares |
CY2022Q2 | urg |
Number Of Options Exercisable
NumberOfOptionsExercisable
|
6133117 | shares |
urg |
Schedule Of Stock Option Fair Value Assumptionstabletextblock
ScheduleOfStockOptionFairValueAssumptionstabletextblock
|
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Stock Options Fair Value Assumptions </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong> 2022 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong> 2021 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected forfeiture rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected life (years) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">72.7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">69.5</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk free rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected dividend rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Black-Scholes value (CAD$) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">$1.22</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">$0.74</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> | ||
urg |
Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate
SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate
|
0.056 | pure | |
urg |
Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate
SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate
|
0.061 | pure | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P3Y10M24D | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P3Y10M24D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.727 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.695 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.019 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.007 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.000 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.000 | pure | |
urg |
Black Scholes Value Cad
BlackScholesValueCad
|
1.22 | ||
urg |
Black Scholes Value Cad
BlackScholesValueCad
|
0.74 | ||
urg |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBeginning
|
1011660 | shares | |
urg |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueBeginning
|
0.69 | ||
urg |
Granted Weighted Average Grant Date Fair Value
GrantedWeightedAverageGrantDateFairValue
|
0.00 | ||
urg |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue
|
0.00 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
0.00 | ||
urg |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding
|
1011660 | shares | |
urg |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding
|
0.69 | ||
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
1011660 | shares |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P0Y7M6D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
1072360000 | usd | |
CY2022Q2 | us-gaap |
Development Costs
DevelopmentCosts
|
1326000 | usd |
CY2021Q2 | us-gaap |
Development Costs
DevelopmentCosts
|
333000 | usd |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1561000 | usd |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1628000 | usd |
CY2021Q1 | urg |
Class Of Warrant Or Right Exercise Price Of Warrants
ClassOfWarrantOrRightExercisePriceOfWarrants
|
1.35 | |
urg |
Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate
RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate
|
0.044 | pure | |
urg |
Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate
RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate
|
0.042 | pure | |
urg |
Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad
RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad
|
1.44 | ||
urg |
Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad
RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad
|
0.63 | ||
CY2020Q3 | urg |
Class Of Warrant Or Right Exercise Price Of Warrants
ClassOfWarrantOrRightExercisePriceOfWarrants
|
0.75 | |
urg |
Class Of Warrant Or Right Outstanding Beginning
ClassOfWarrantOrRightOutstandingBeginning
|
24368530 | shares | |
urg |
Class Of Warrants Or Right Shares Issued On Exercise Beginning
ClassOfWarrantsOrRightSharesIssuedOnExerciseBeginning
|
12184265 | shares | |
urg |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Beginning
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Beginning
|
1.16 | ||
urg |
Number Of Warrants Exercised
NumberOfWarrantsExercised
|
-518000 | shares | |
urg |
Number Of Shares To Be Issued Upon Exercise Exercised
NumberOfSharesToBeIssuedUponExerciseExercised
|
-259000 | shares | |
urg |
Per Share Exercise Price Exercised
PerShareExercisePriceExercised
|
0.75 | ||
urg |
Class Of Warrant Or Right Outstanding Ending
ClassOfWarrantOrRightOutstandingEnding
|
23850530 | shares | |
urg |
Class Of Warrants Or Right Shares Issued On Exercise Ending
ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding
|
11925265 | shares | |
urg |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending
|
1.17 | ||
urg |
Disposal Billings
DisposalBillings
|
19000 | usd | |
CY2021Q2 | urg |
Disposal Billings
DisposalBillings
|
7000 | usd |
CY2021Q2 | us-gaap |
Accretion Expense
AccretionExpense
|
123000 | usd |
CY2022Q2 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
3460000 | usd |
CY2021Q2 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
2777000 | usd |
CY2022Q2 | urg |
Cost Of Product Sale
CostOfProductSale
|
0 | usd |
urg |
Cost Of Product Sale
CostOfProductSale
|
0 | usd | |
urg |
Cost Of Product Sale
CostOfProductSale
|
0 | usd | |
CY2021Q2 | urg |
Cost Of Product Sale
CostOfProductSale
|
0 | usd |
CY2022Q2 | urg |
Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
|
1662000 | usd |
CY2021Q2 | urg |
Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
|
1835000 | usd |
urg |
Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
|
3384000 | usd | |
urg |
Lower Of Cost Or Nrv Adjustments
LowerOfCostOrNRVAdjustments
|
3508000 | usd | |
CY2022Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1662000 | usd |
CY2021Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1835000 | usd |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
3384000 | usd | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
3508000 | usd | |
CY2022Q2 | us-gaap |
Exploration Expense
ExplorationExpense
|
460000 | usd |
CY2021Q2 | us-gaap |
Exploration Expense
ExplorationExpense
|
693000 | usd |
us-gaap |
Exploration Expense
ExplorationExpense
|
999000 | usd | |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
43267000 | usd |
CY2021Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
21491000 | usd |
CY2022Q2 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
8026000 | usd |
CY2021Q2 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
7860000 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
51293000 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
29351000 | usd |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
400000 | usd | |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
400000 | usd | |
CY2022Q2 | urg |
Deposit Held In Canada And Us
DepositHeldInCanadaAndUs
|
600000 | usd |